Physician

Anthony Joseph Badame, M.D.

According to 2025 Medicare claims, Anthony Badame, M.D. (NPI: 1285676551) practices dermatology in the San Jose-Sunnyvale-Santa Clara, CA market, with the plurality of this provider's patient population coming from Santa Clara, CA. This provider's primary affiliated billing organization is ANTHONY J BADAME MD A PROFESSIONAL CORPORATION (NPI: 1699509059; TIN: 770280491) and primary practice location at 95128-4806.

Badame's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 980 traditional Medicare patients, billed 8,223 HCPCS/CPT codes, and received $3,590,238 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,508 prescription claims across 509 beneficiaries totaling $108,138 in drug costs, led by Jublia (Efinaconazole). DME data shows 12 claims. Open Payments data shows 12 records totaling $525. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $474,562 to $3,590,238. Similarly, Part D prescription costs have risen steadily, from $70,928 to $108,138. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,042	7,365	$474,562
2016	1,007	7,371	$587,403
2017	1,025	7,790	$624,604
2018	993	6,741	$531,402
2019	1,040	6,730	$547,683
2020	823	4,931	$442,318
2021	955	5,752	$522,464
2022	1,010	5,736	$475,677
2023	978	5,917	$561,433
2024	980	8,223	$3,590,238

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	402	1,163	$70,928
2016	437	1,356	$69,586
2017	437	1,232	$53,141
2018	439	1,321	$60,373
2019	467	1,338	$64,215
2020	428	1,288	$64,653
2021	470	1,394	$56,926
2022	479	1,363	$77,821
2023	501	1,409	$91,974
2024	509	1,508	$108,138

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	12	$1,099
2023	N/R	12	$1,293
2024	N/R	12	$1,326

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	267	326	$111
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	206	206	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	760	1,375	$77
17000	Destruction of precancer skin growth, 1 growth	438	605	$50
17003	Destruction of precancer skin growth, 2-14 growths	308	1,542	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jublia	Efinaconazole	15	450	$11,119
Clobetasol Propionate	Clobetasol Propionate	41	1,086	$3,304
Ketoconazole	Ketoconazole	140	4,315	$2,426
Mometasone Furoate	Mometasone Furoate	103	3,017	$2,413
Betamethasone Dipropionate	Betamethasone Dipropionate	62	1,679	$2,256

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4419	Ostomy pouch, closed; for use on barrier with non-locking flange, with filter (2 piece), each	N	N/R	12	$1,326

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$525	Galderma Laboratories, L.P.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anthony Joseph Badame, M.D.?

Tedicare shows public-source Medicare data for Anthony Joseph Badame, M.D. (NPI 1285676551), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anthony Joseph Badame, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anthony Joseph Badame, M.D.?

Anthony Joseph Badame, M.D. is linked to ANTHONY J BADAME MD A PROFESSIONAL CORPORATION (billing NPI 1699509059) in the available physician profile data.

Does Anthony Joseph Badame, M.D. have Open Payments data?

Anthony Joseph Badame, M.D. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.